AVS Nutrition sold to Singaporean Healthcare group, Veritas

26.9.2018

AVS Nutrition Ltd, a leading contract manufacturer of food, vitamin, supplement and complementary medicine, was sold to Verita Healthcare Group Ltd, a Singapore-based group providing preventative healthcare solutions.

AVS provides a range of services to brands looking for an alternate supplier or to those looking for new concepts; from sourcing, supplying, packaging and contract manufacturing to development of customised products and innovative formulations. The business is based in Ballina, NSW.

The shareholders of AVS were seeking a partner to help grow, as well as realize some liquidity for their investment in the business.

Clairfield introduced AVS to Verita Healthcare Group. Verita was seeking to expand its presence in Australia, complementing its existing presence. Clairfield represented AVS throughout the transaction process, including introducing the investor, managing due diligence advisors, and working closely with both the buyer and seller to ensure a transaction structure which created alignment for all parties.

InterFinancial  acted as exclusive financial advisor to AVS Nutrition.

Transactions of this nature can be challenging and time consuming. Clairfield Australia (InterFinancial) connected us with an interested party, managed the process of negotiations and due diligence, and ultimately we’ve ended up in a position where all parties have achieved a really positive outcome. Having had their guidance and follow up in the background along the entire way has been invaluable to us, whilst we’ve continued to run our business from day to day.
— Mikko Helle, CEO

Deal team:

Mark Steinhardt
Anthony Vago
Andrew Wheeler

26.3.2024

Sector Dashboards March 2024

Our monthly dashboards cover seven key sectors of focus, with each sector built up by several subsectors that cover similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the Australian Stock Exchange that are actively traded and covered by research analysts, and hence have […]

Read more
26.3.2024

M&A and ultrarunning – the five similarities

Running an M&A process is similar to ultrarunning according to Mark Steinhardt, InterFinancial Executive Director. He’s done a fair bit of both so, after slogging it out over 80kms in Noosa recently, he decided to pen his thoughts on the similarities between M&A and ultrarunning. Originally shared as an article on Mark’s LinkedIn here: ________________ […]

Read more
25.3.2024

InterFinancial supports DDH Graham to complete cross-border corporate lift-out

Established in 1981, DDH Graham offers a wide range of investment products and services including cash management accounts, a variety of managed funds as well as super and non-super administration capabilities. With the leader of its administration business transitioning into retirement and increased regulation and market consolidation, DDH sought to explore options for potential partners […]

Read more
29.2.2024

ASX-listed Microba expands offering and UK footprint with IFL

Over the last 10 years, our understanding of the importance of the gut to overall health has jumped forward in leaps and bounds. It is now well understood that microorganisms, including bacteria, archaea, fungi, and viruses living inside the human digestive tract (known collectively as the gut microbiome) are critical to many bodily functions. Not […]

Read more
29.2.2024

Sector Dashboards February 2024

Our monthly dashboards cover seven key sectors of focus, with each sector built up by several subsectors that cover similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the Australian Stock Exchange that are actively traded and covered by research analysts, and hence have […]

Read more
27.2.2024

Australia has a critical role in the global EV industry 

There is enormous growth and opportunity in the global Electric Vehicle (EV) industry and Australia has a critical role to play in the future. According to Clairfield International’s H2 2023 Global Electric Mobility Sector update global EV sales grew 70% in both 2022 and 2023 reaching $US1,573 billion. One of the primary drivers behind this […]

Read more
Clean Energy
05.2.2024

Will German clean energy demand be Australia’s hydrogen mega opportunity? 

Written by Derek Thomson – Director Clean Energy and ESG Motivated by their desire to reduce greenhouse gases, Germany has made bold decisions to turn off nuclear and coal power generation and transition to clean energy. German leaders have made these decisions in the full knowledge it will be temporarily dependent on imported gas. What […]

Read more
31.1.2024

Sector Dashboards January 2024

Our monthly dashboards cover seven key sectors of focus, with each sector built up by several subsectors that cover similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the Australian Stock Exchange that are actively traded and covered by research analysts, and hence have […]

Read more
Is a Goldilocks year a good time to sell your business?
30.1.2024

Is a ‘Goldilocks’ year a good time to sell your business?

Written by Brad Shaw. When it comes to the state of the market, many have been referring to 2024 as a ‘Goldilocks’ year which feels like a good way to put it. Things aren’t too hot or too cold, they’re just right. But, what does that actually mean? Is 2024 a good year to sell […]

Read more